Soriano V - Search Results

1

Dynamics of enfuvirtide resistance in HIV-infected patients during and after long-term enfuvirtide salvage therapy.

Poveda E, Rodés B, Lebel-Binay S, Faudon JL, Jimenez V, Soriano V. Poveda E, et al. Among authors: soriano v. J Clin Virol. 2005 Dec;34(4):295-301. doi: 10.1016/j.jcv.2005.02.004. J Clin Virol. 2005. PMID: 16286053

2

Prevalence of G333D/E in naive and pretreated HIV-infected patients.

Gallego O, Corral A, de Mendoza C, Rodés B, Soriano V. Gallego O, et al. Among authors: soriano v. AIDS Res Hum Retroviruses. 2002 Aug 10;18(12):857-60. doi: 10.1089/08892220260190335. AIDS Res Hum Retroviruses. 2002. PMID: 12201908

3

Evolution of the gp41 env region in HIV-infected patients receiving T-20, a fusion inhibitor.

Poveda E, Rodés B, Toro C, Martín-Carbonero L, Gonzalez-Lahoz J, Soriano V. Poveda E, et al. Among authors: soriano v. AIDS. 2002 Sep 27;16(14):1959-61. doi: 10.1097/00002030-200209270-00014. AIDS. 2002. PMID: 12351957 No abstract available.

4

Rapid assessment of phenotypic resistance to protease inhibitors in human immunodeficiency virus type 1 group O.

Rodés B, Poveda E, Soriano V. Rodés B, et al. Among authors: soriano v. J Clin Microbiol. 2002 Nov;40(11):4313-6. doi: 10.1128/JCM.40.11.4313-4316.2002. J Clin Microbiol. 2002. PMID: 12409418 Free PMC article.

5

Can drug resistance mutations influence the measurement of plasma HIV-RNA by different viral load techniques?

Poveda E, de Mendoza C, Cuesta M, Toro C, Rodés B, Soriano V. Poveda E, et al. Among authors: soriano v. AIDS Patient Care STDS. 2003 Jul;17(7):321-4. doi: 10.1089/108729103322231259. AIDS Patient Care STDS. 2003. PMID: 12952733

6

Are fusion inhibitors active against all HIV variants?

Poveda E, Rodes B, Toro C, Soriano V. Poveda E, et al. Among authors: soriano v. AIDS Res Hum Retroviruses. 2004 Mar;20(3):347-8. doi: 10.1089/088922204322996590. AIDS Res Hum Retroviruses. 2004. PMID: 15117459

7

Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection.

Rodés B, Toro C, Paxinos E, Poveda E, Martinez-Padial M, Benito JM, Jimenez V, Wrin T, Bassani S, Soriano V. Rodés B, et al. Among authors: soriano v. AIDS. 2004 May 21;18(8):1109-16. doi: 10.1097/00002030-200405210-00004. AIDS. 2004. PMID: 15166526

8

Evolution of genotypic and phenotypic resistance to Enfuvirtide in HIV-infected patients experiencing prolonged virologic failure.

Poveda E, Rodés B, Labernardière JL, Benito JM, Toro C, González-Lahoz J, Faudon JL, Clavel F, Schapiro J, Soriano V. Poveda E, et al. Among authors: soriano v. J Med Virol. 2004 Sep;74(1):21-8. doi: 10.1002/jmv.20141. J Med Virol. 2004. PMID: 15258964 Clinical Trial.

9

Viral response to antiretroviral therapy in a patient coinfected with HIV type 1 and type 2.

Rodés B, Toro C, Jiménez V, Soriano V. Rodés B, et al. Among authors: soriano v. Clin Infect Dis. 2005 Jul 15;41(2):e19-21. doi: 10.1086/431204. Epub 2005 May 31. Clin Infect Dis. 2005. PMID: 15983906

10

Enfuvirtide is active against HIV type 1 group O.

Poveda E, Barreiro P, Rodés B, Soriano V. Poveda E, et al. Among authors: soriano v. AIDS Res Hum Retroviruses. 2005 Jun;21(6):583-5. doi: 10.1089/aid.2005.21.583. AIDS Res Hum Retroviruses. 2005. PMID: 15989465

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,490 results

Search Page

Filters